US Patent 10035849 Methods and compositions for targeting polyubiquitin
Patent 10035849 was granted and assigned to Genentech on July, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+119 characters)
Article
Patent abstract
Anti-K63-linked polyubiquitin monoclonal antibodies, and methods for using the antibodies, are provided.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Marissa Matsumoto0
Robert F. Kelley0
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 24 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
100358490
Date of Patent
July 31, 2018
0Patent Application Number
151536440
Date Filed
May 12, 2016
0Patent Citations Received
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 16 Mar, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 7 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 21 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10035849 Methods and compositions for targeting polyubiquitin
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10035849
Date of patent
July 31, 2018
Patent application number
15153644
Date Filed
May 12, 2016
Patent primary examiner
Find more entities like US Patent 10035849 Methods and compositions for targeting polyubiquitin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
